Aurora Italia
About Aurora Italia
Italian arm of Aurora Cannabis supplying pharmaceutical-grade medical cannabis to the Italian market through authorised distribution channels.
Key Facts
- 1Parent company Aurora Cannabis is one of Canada's largest licensed producers
- 2Supplies Italian pharmacies via partnerships with local pharmaceutical distributors
Latest News
Aurora Cannabis Faces Fresh Scrutiny as Analysts Reassess Fundamentals
ACB stock draws renewed analyst attention amid shifting cannabis market dynamics and evolving investor expectations for profitability.
Aurora Cannabis Plunges 28%: Analyzing the Three-Month Selloff
ACB shares face mounting pressure as cannabis sector headwinds intensify. We examine whether the 28% decline creates opportunity or signals deeper troubles ahead.
Aurora Cannabis Leverages Medical Expansion to Drive International Revenue
ACB's strategic focus on global medical cannabis markets positions the company for sustainable growth amid challenging recreational headwinds.
Aurora Cannabis Stock Surges Following Record Annual Results
ACB shares climb as the Canadian cannabis producer reports its strongest annual performance, signaling potential turnaround for the struggling sector.
Aurora Cannabis Breaks Ground as First Cannabis Firm on TIME's Best List
ACB earns historic recognition on TIME Canada's Best Companies 2026, signaling potential shift in institutional perception of cannabis sector legitimacy.
Frequently Asked Questions
What products does Aurora supply in Italy?
GMP-certified dried cannabis flower and standardised cannabis oil preparations for medical use.
Is a prescription required?
Yes, all Aurora Italia products require a physician's prescription and are dispensed only through pharmacies.
More Cannabis Companies in Milan
Cannabis Laws
Products
- Medical cannabis flower
- Standardised cannabis oils
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Milan, Italy
- Founded
- 2019
- Publicly Traded
- Yes
- Ticker
- TSX:ACB